Related Experiment Video
Updated: Jun 1, 2026
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Gastric metastasis of breast cancer: a single centre retrospective study
Maher M Almubarak1, Marick Laé, Wulfran Cacheux
1Department of Surgery, Curie Institute, Paris, France.
Background:
Digestive metastasis of breast cancer are rare but when they do occur the stomach is one of the commoner sites.
Aim:
To describe the clinical, endoscopic, pathological features and treatment.
Methods:
35 cases of gastric metastasis were identified retrospectively between 1980 and 2008.
Results:
The location of the gastric metastasis was fundus (n=15, 43%), antrum (n=15, 43%) or both (n=5, 14%). The histological subtype of primary breast cancer was invasive lobular carcinoma in 34 patients (97%). Hormonal receptors were positive in 19 out of 24 cases (79%), two out of 22 analysed were HER2 positive (9%). There were 16 (46%) patients with peritoneal carcinosis. The treatment was chemotherapy (n=13, 37%), hormonotherapy (n=2, 6%) or both (n=13, 37%). The 2-year survival rate after gastric metastasis diagnosis was 53% with a median follow up of 31 months [7-84 months].
Conclusion:
Ninety-seven percent of gastric metastasis from breast cancers are derived from invasive lobular carcinoma. Seventy-nine percent of these are HER+ and comparison with the original histopathological slides of primary breast carcinoma should be performed to differentiate gastric metastasis from primary gastric carcinoma. Peritoneal carcinomatosis accompanied gastric metastasis in almost half the cases in this series and treatment was generally chemotherapy.
